awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47197303-B6A1F399-52FD-4035-A42C-63CA05A6B65C
Q47197303-B6A1F399-52FD-4035-A42C-63CA05A6B65C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47197303-B6A1F399-52FD-4035-A42C-63CA05A6B65C
ADAM17-overexpressing breast cancer cells selectively targeted by antibody-toxin conjugates.
P2860
Q47197303-B6A1F399-52FD-4035-A42C-63CA05A6B65C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47197303-B6A1F399-52FD-4035-A42C-63CA05A6B65C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd2611970ef8a0442dde5d12b46f8f82145dd401
P2860
Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors.